Impact of Sarcopenia on Outcomes Following Resection of Pancreatic Adenocarcinoma

Body composition and outcome in patients undergoing resection of colorectal liver metastases

(2012) M. G. van Vledder et al.   BRITISH JOURNAL OF SURGERY

Sarcopenia as a Prognostic Factor among Patients with Stage III Melanoma

(2011) Michael S. Sabel et al.   ANNALS OF SURGICAL ONCOLOGY

Estimation of Physiologic Ability and Surgical Stress Score Does Not Predict Immediate Outcome After Pancreatic Surgery

(2011) Simone Deyle et al.   PANCREAS

Body composition in patients with non−small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis

(2010) Vickie E Baracos et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma

(2010) S. Antoun et al.   ANNALS OF ONCOLOGY

Muscle Wasting in Cancer Cachexia: Clinical Implications, Diagnosis, and Emerging Treatment Strategies

(2010) Shontelle Dodson et al.   Annual Review of Medicine

Association of Skeletal Muscle Wasting With Treatment With Sorafenib in Patients With Advanced Renal Cell Carcinoma: Results From a Placebo-Controlled Study

(2010) Sami Antoun et al.   JOURNAL OF CLINICAL ONCOLOGY

Sarcopenia and Mortality after Liver Transplantation

(2010) Michael J. Englesbe et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Frailty as a Predictor of Surgical Outcomes in Older Patients

(2010) Martin A. Makary et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Evolving classification systems for cancer cachexia: ready for clinical practice?

(2010) David Blum et al.   SUPPORTIVE CARE IN CANCER

Can the physiologic ability and surgical stress (E-PASS) scoring system predict operative morbidity after distal pancreatectomy?

(2010) Daisuke Hashimoto et al.   SURGERY TODAY

The Clavien-Dindo Classification of Surgical Complications

(2009) Pierre A. Clavien et al.   ANNALS OF SURGERY

A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer

(2009) H Ueno et al.   BRITISH JOURNAL OF CANCER

Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer

(2009) B. H.L. Tan et al.   CLINICAL CANCER RESEARCH

Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment

(2009) C. M.M. Prado et al.   CLINICAL CANCER RESEARCH

Excessive Loss of Skeletal Muscle Mass in Older Adults With Type 2 Diabetes

(2009) S. W. Park et al.   DIABETES CARE

Combined Resistance and Aerobic Exercise Program Reverses Muscle Loss in Men Undergoing Androgen Suppression Therapy for Prostate Cancer Without Bone Metastases: A Randomized Controlled Trial

(2009) Daniel A. Galvão et al.   JOURNAL OF CLINICAL ONCOLOGY

The emerging role of computerized tomography in assessing cancer cachexia

(2009) Carla MM Prado et al.   Current Opinion in Supportive and Palliative Care

A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care

(2008) Marina Mourtzakis et al.   Applied Physiology Nutrition and Metabolism

Determining Pattern of Recurrence Following Pancreaticoduodenectomy and Adjuvant 5-Flurouracil-Based Chemoradiation Therapy: Effect of Number of Metastatic Lymph Nodes and Lymph Node Ratio

(2008) Bolanle Asiyanbola et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Effect of hospital volume on outcome of pancreaticoduodenectomy in Italy

(2007) G. Balzano et al.   BRITISH JOURNAL OF SURGERY

POSSUM accurately predicts morbidity for pancreatic resection

(2007) Wande Pratt et al.   SURGERY